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Research article 
Postpartum depression and thyroid dysfunction– 
should pregnant women be screened for 
thyroid disorders? 
 
Anca A. Simionescu1, Erika Marin2 
 
1Carol Davila University of Medicine and Pharmacy, Filantropia Hospital, Bucharest, Romania  
2Academy of Economic Studies, Department of Statistics and Econometrics, Bucharest, Romania 
Abstract The relationship between thyroid dysfunction and postpartum depression has been 
investigated for quite some time now, but no consensus has been reached regarding the need for 
screening for thyroid function during pregnancy. This paper aims to investigate whether thyroid 
hormone screening in pregnancy might contribute to the diagnosis of postpartum depression. 
Depression was assessed using the Edinburgh Postnatal Depression Scale (EPDS) - one of the 
most widely used measures in detecting postpartum depression and anxiety. Thyroid function was 
measured using the commonly recommended thyroid laboratory tests. 
A structured questionnaire was given to 61 patients closely monitored during their pregnancy 
and at least one year after giving birth, including for thyroid and depression disorders. The 
questionnaire was completed anonymously online by the patients and had three sections: one 
containing the EPDS questions, one assessing thyroid function, and a demographic section. 
The interdependency between thyroid and depression was analyzed in SPSS using the Pearson 
chi-square test of independence. The results show no statistically significant relationship between 
thyroid dysfunction and depression. In other words,  women suffering from thyroid dysfunctions 
have no greater rate of depression compared to women without thyroid dysfunction. As a result, it 
screening for thyroid disorders during pregnancy may not provide relevant information for 
detecting postnatal depression. 
 
 Keywords  Postpartum depression (PPD), thyroid dysfunction, Edinburgh Postnatal Depression 
Scale (EDPS) 
Highlights  This study found no difference in postpartumdepression for women with thyroid 
dysfunction compared to women without thyroid dysfunction. 
 The study pinpoints the need for appropriate and constant assessment of postpartum 
depression in Romania and the creation of an appropriate medical structure to identify 
and mitigate the risks of postpartum depression. 
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Introduction 
Postpartum depression (PPD) is defined as a non-
psychotic depressive episode that can last from one month 
up to one year after birth (1).  If left undiagnosed, the 
disorder may have negative consequences, on both the 
mother and the child. It is estimated that PPD affects 10 to 
15% of new mothers (2, 3). Mothers’ postpartum mood 
disturbance may lead to an increased risk of affecting the 
child’s cognitive capacity, social skills, and long-term 
affections. (4). However, less than half of postnatal 
depression cases are detected through routine clinical 
practice (5). 
Thyroid disorders are among the most common 
endocrine pathologies during pregnancy and the 
postpartum period. The prevalence of thyroid dysfunction 
in postpartum ranges between 1.1 % and 16.7 % across 
the country (6). Studies have shown that maternal thyroid 
autoimmunity was associated with postpartum depression  
(7). The majority of women predisposed to develop 
postpartum thyroiditis have subclinical thyroid 
autoimmune disease manifestations early in the pregnancy 
(e.g. hyperemesis gravidorum). At the postpartum visit, 
thyroiditis does not necessarily manifest clinically and 
thus it is important that physicians be aware of the risks of 
thyroid disorders. 
Nevertheless, in everyday practice there are 
insufficient data to recommend universal screening for 
thyroid in pregnancy, and, in the absence of clinical 
symptoms, treatment is unnecessary (8, 9). 
In Romania, screening for neonatal hypothyroidism 
has been performed at birth since 1979. The incidence of 
hypothyroidism is 1 in 3,409 new-born babies (10). 
Currently, several postpartum screening tools are used 
for identifying depression, such as Hamilton Depression 
Rating Scale – HDRS, developed by Hamilton in 1960; 
Cronhom – Ottoson scale, also introduced in 1960; 
Melancholia Scale – introduced by Bech and Rafaelse in 
1980; Montgomery – Asberg Depression Rating Scale – 
MADRS, developed in 1976, as well others, many based 
on the Hamilton scale. 
The Edinburgh Postnatal Depression Scale (EDPS) 
was developed by Cox and collaborators in 1987 (11). 
The aim of the scale was to identify women suffering 
from postpartum depression. The scale was initially tested 
in Edinburgh and Livingston and consisted of 10 
questions with responses on a Likert scale (see Figure 1). 
Studies conducted on the scale’s validity showed that 
almost 92 percent of women suffering from postpartum 
depression are correctly diagnosed using the EDPS. 
However, the scale is used only as a screening tool and 
not as a diagnostic tool in the public health system, i.e., a 
diagnosis of depression should be made only by 
specialized healthcare providers. Nevertheless, the EPDS 
scale is a useful tool for providing preliminary 
information.  
The objective of this article is to test whether there is a 
relationship between thyroid dysfunction (diagnosed 
before, during, or after pregnancy) and postnatal 
depression. 
The analysis is performed based on questionnaires 
completed by mothers one year or more after birth, 
retrospectively assessing their postpartum depression at 3 
months after birth, based on the Edinburgh Scale and also 
answering questions related to thyroid disorders. The aim 
is to assess if patients known for thyroid pathologies or 
those who later discovered their thyroid problems are 
more likely to suffer from postpartum depression, thereby 
establishing a link between the two disorders. If so, the 
need for screening for thyroid disorders during pregnancy 
might be justified. 
Materials and Methods 
We performed a structured questionnaire-based study 
on 61 women at least one year after birth, our goal being 
to assess the relationship between thyroid dysfunction and 
postpartum depression.  
The two variables - thyroid function and postpartum 
depression - were measured as follows: the first used T3, 
T4, and TSH laboratory tests; the second, depression, was 
assessed using the Edinburgh Postnatal Depression Scale 
– EDPS. 
Women were tested during pregnancy for thyroid 
function (T3, T4 and TSH) and monitored for at least one 
year after birth (including thyroid dysfunction and 
psychiatric disorders). We included only women with 
full-term birth; we excluded patients with high risk 
pregnancies: prematurity, malformations, etc. that might 
lead to depression. Patients with thyroid carcinoma or 
undergoing hormonal replacement therapy were excluded 
as well.  
The questionnaire was distributed to 65 women in 
February 2017, and 61 valid anonymous surveys were 
introduced in the data base. Consent forms for the use of 
personal data in this study were signed beforehand.  
The questionnaire was structured in three sections: one 
containing socio-demographic questions, one assessing 
the thyroid function, and one regarding self-assessed well-
being based on Edinburg depression Scale – completed 
one year or more after birth regarding their state at 3 
months after giving birth.  
Regarding demographic aspects, respondents were 
mainly from Bucharest and neighboring counties. At the 
time of child birth, the youngest mother was 21 and the 
oldest 41 years. The average mother’s age at delivery was 
30.6 years – close to the median age of 30 years 
(indicating that half of the mothers are 30 years old or 
younger and the other half are 30 years old or more). 
The section related to thyroid gland functioning was 
summarized in the following three variables:  
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 Variable 1 – a variable showing if the patient had or 
did not have thyroid issues before pregnancy; 
 Variable 2 – a variable showing if the patient 
underwent or did not undergo treatment for the thyroid 
before pregnancy; 
 Variable 3 – a variable showing if the patient 
underwent or did not undergo treatment for the thyroid 
during pregnancy or immediately after (in the first 
year after giving birth). 
The last of the three sections was based on the 
Edinburgh Postnatal Depression Scale (EPDS). This test 
to evaluate postpartum depression consists of ten 
questions answered by the mother. Responses have four 
possibilities, scored from 0 to 3, with overall scores 
linked to the severity of the symptoms. The cut-off scores 
for depression have typically ranged from 9 to 13 points. 
Based on the score, the patients in our sample were 
included in one of the two categories: With or Without 
depression, with 10 points serving as the cut-off point). 
 
The EPDS results were cross-tabulated against the 
three thyroid-related variables. The Pearson Chi 
squared test was used to test whether depression (Yes/ 
No based on the EPDS scale) and thyroid dysfunction 
(hypo- or hyperthyroidism - before or after pregnancy) 
are associated. This test was chosen as each of 
the two/paired variables are measured on a categorical 
or ordinal scale, and the two variables consist of two or 
more categorical independent groups. Data analysis 
was performed using SPSS Software.  
Results 
The assessment of depression based on the ten EPDS 
questions is summarized in Figure 1. Each question is 
separately presented as well as an overall distribution of 
responses.  
Responses to questions 1, 2, and 4 are scored 0, 1, 2, 
or 3 according to increased severity of the symptom. The 
rest of the questions are marked with an asterisk (*) 
meaning that they were reverse scored (i.e. 3, 2, 1, and 0).
Q1 Was able to laugh and see the 
funny side of things
No of 
pacients
Percentage Q6* Things have been getting on top of me
No of 
pacients
Percentage
As much as I always could 34 55.7%
Yes, most of the time I haven’t been able to 
cope at all 18 25.0%
Not quite so much now 17 27.9%
Yes, sometimes I haven’t been coping as 
well as usual 18 25.0%
Definitely not so much now 9 14.8% No, most of the time I have coped quite well 18 25.0%
Not at all 1 1.6% No, have been coping as well as ever 18 25.0%
Q2 Have looked forward with enjoyment 
to things 
No of 
pacients
Percentage
Q7* Have been so unhappy that I have had 
difficulty sleeping
No of 
pacients
Percentage
As much as I ever did 44 72.1% Yes, most of the time 5 8.2%
Rather less than I used to 13 21.3% Yes, sometimes 8 13.1%
Definitely less than I used to 4 6.6% Not very often 13 21.3%
Hardly at all 0 0.0% No, not at all 35 57.4%
Q3* Have blamed yourself 
unnecessarily when things went wrong
No of 
pacients
Percentage Q8* Have felt sad or miserable
No of 
pacients
Percentage
Yes, most of the time 16 26.2% Yes, most of the time 4 6.6%
Yes, some of the time 21 34.4% Yes, quite often 8 13.1%
Not very often 10 16.4% Not very often 18 29.5%
No, never 14 23.0% No, not at all 31 50.8%
Q4 Have been anxious or worried for no 
good reason 
No of 
pacients
Percentage
Q9* Have been so unhappy that I have been 
crying
No of 
pacients
Percentage
No, not at all 20 32.8% Yes, most of the time 5 8.2%
Hardly ever 18 29.5% Yes, quite often 6 9.8%
Yes, sometimes 19 31.1% Only occasionally 15 24.6%
Yes, very often 4 6.6% No, never 35 57.4%
Q5* Have felt scared or panicky for no 
very good reason
No of 
pacients
Percentage
Q10* The thought of harming myself has 
occurred to me
No of 
pacients
Percentage
Yes, quite a lot 5 8.2% Yes, quite often 1 1.6%
Yes, sometimes 12 19.7% Sometimes 1 1.6%
No, not much 15 24.6% Hardly ever 4 6.6%
No, not at all 29 47.5% Never 55 90.2%
Figure 1. Assessing depression - distribution of answers to the EPDS questions. Question 10 is important due 
to signaling the potential suicidal behavior. The data show that two out of the 61 patients often thought about 
harming themselves.  The total score is determined by summing up the scores for each of the 10 items. The 
score distribution is presented in Figure 2. 
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According to the literature, the cut-off score is 
between 9-13 – higher values signaling the possibility of 
post- partum depression. In our sample, a score of 10 was 
considered the cut-off score, thus erring on the side of 
caution. The chart below shows that, although most of the 
patients’ scores are on the lower side of the scale, 38% 
scored above 10, indicating symptoms of postpartum 
depression (see Figure 3). 
 
Figure 3. The postpartum depression risk structure 
of patients 
Responses to questions assessing thyroid disorders 
before, during, or after pregnancy are summarized in 
Table 1. 
Table 1. Summary of thyroid disorder-related 
questions 
  
No Yes 
Don’t Know/ 
Don’t answer 
Variable 1: thyroid issues 
before pregnancy 
75.4% 11.5% 13.1% 
Variable 2: treatment for 
thyroid before pregnancy 
85.2% 11.5% 3.3% 
Variable 3: treatment for 
thyroid during pregnancy 
or immediately after (in 
the first year after birth) 
85.2% 13.1% 1.6% 
Of the 61 mothers, only seven had had thyroid-related 
medical issues before pregnancy and consequently 
underwent appropriate treatment. The number increased 
to eight with thyroid disorders who underwent treatment 
during or after pregnancy. 
We cross-tabulated these two variables to assess their 
interdependency, with results presented in Figure 4. None 
of the three analyses were significant. Consequently, 
these two variables, postpartum depression and thyroid 
disorder, occurred independently of one another. 
Figure 4.  SPSS Results of Pearson chi-square test of 
independence 
EDS _Depression_Yes/No_3 months * before pregnancy 
thyroid problems? Cross-tabulation 
 
Before pregnancy thyroid 
problems? Total 
No Yes Don't know 
EDS_Depression 
_3mo* 
No 29 4 5 38 
Yes 17 3 3 23 
Total 46 7 8 61 
 
Chi-Square Tests 
 Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square .090a 2 .956 
Likelihood Ratio .089 2 .956 
Linear-by-Linear 
Association 
.000 1 .985 
No. of Valid Cases 61   
 
EDS _Depression_3 months * treatment before pregnancy 
Cross-tabulation 
 
Thyroid treatment before 
pregnancy 
Total 
No Yes 
Don't know 
/Not sure 
EDS_Depression 
_3 mo* 
No 33 4 1 38 
Yes 19 3 1 23 
Total 52 7 2 61 
 
Chi-Square Tests 
 Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square .238a 2 .888 
Likelihood Ratio .233 2 .890 
No. of Valid Cases 61   
 
 
Figure 2. EPDS score distribution for the 
group of patients 
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EDS _Depression_3 months * Treatment pregnancy or after 
Cross-tabulation  
 
Treatment pregnancy 
+ after Total 
0 1 9 
EDS _Depression 
_3 mo 
No 33 4 1 38 
Yes 19 4 0 23 
Total 52 8 1 61 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 1.150a 2 .563 
Likelihood Ratio 1.476 2 .478 
No. of Valid Cases 61   
Discussion 
The results demonstrate the complexity of postpartum 
depression. From the total of 61 women, 23 had a score of 
10 or more out of a possible 30 points. In other words, 
38% of the patients presented signs ofpostpartum 
depression three months after giving birth. Moreover, the 
last question in the EPDS scale identified two patients 
who exhibited suicidal risks. 
In terms of thyroid disorders, all patients were 
monitored during pregnancy. Seven (11.5%) had had pre-
pregnancy thyroid disorders. One patient was diagnosed 
and treated for thyroid disorders during pregnancy and 
displayed no signs of depression. 
From the seven patients diagnosed with pre-pregnancy 
disorders, three had an EPDS score indicating depression 
signs, and four were not affected by postpartum 
depression. 
Although the interaction mechanism between thyroid 
dysfunctions and psychological disorders is not fully 
understood, clinical investigations have recognized the 
interdependency between the two disorders (7). The 
association between thyroid function and postpartum 
mood disorders was seen in Greek women, where lower 
levels of FT3 and FT4 serum were linked to increased 
mood disturbances in the first postpartum week (12).  
Our aim was to identify signs of interdependency 
between thyroid dysfunctions before or during pregnancy 
or after giving birth and postpartum depression measured 
by the Edinburgh Postnatal Depression Scale (EPDS).  
However, our data indicate no relationship between 
thyroid disorder and postpartum depression, as indicated 
by the Chi Square test.    
These results are similar to other research works. 
Iseme et al. showed no association between depression 
and thyroid autoantibodies, based on a group of 2,049 
subjects (13). Moreover, treatment with thyroxine 
administered to thyroid antibody positive women showed 
no impact on reducing the incidence of postpartum 
depression (14). Rather, postpartum depression may be 
more associated with other factors, including 
psychosocial stressors, previous psychiatric history, 
complications during pregnancy, or the delivery process 
itself (15, 16).  
The study has limitations, as it was performed on a 
relatively small group of 61 patients, and the number of 
patients diagnosed with thyroid disorders was even 
smaller (seven patients with existing disorders before 
pregnancy plus one person diagnosed with thyroid 
disorder during pregnancy). Moreover, patients were 
predominantly from Bucharest or nearby Ilfov county 
(65.6 percent of the overall number), the rest being from 
other counties. The geographic distribution of postpartum 
depression is fairly similar to the total distribution. In 
terms of thyroid disorder, of the seven patients diagnosed 
before pregnancy, four were from Bucharest, one from 
Ilfov, and two from other counties. The size of the group 
did not allow identification of endemic regions for thyroid 
disorders (17-19). 
Another limitation of the study could be the 
retrospective assessment of depression using the EPDS 
questions. Specifically, patients were asked to evaluate 
their depression at three months after birth, but the EPDS 
questions were answered one year after birth. Additional 
data were not available as to whether patients had 
received any psychological counselling during or after 
pregnancy (20, 21).  
Conclusions 
The relationship between postpartum depression 
(measured on the EPDS scale, three months after birth) 
and thyroid dysfunctions (discovered and treated before 
pregnancy or during pregnancy) was investigated and 
statistically tested in order to assess any relationship 
between these variables. 
This study found no relationship between 
postpartuem depression and thyroid dysfunction. Thus, 
thyroid screening during pregnancy may not be useful. 
Nevertheless, the study shows a percentage of women 
suffering from postpartum depression (an estimate of 
38%), exceeding the 10 to 15 percent reported in other 
studies. At the same time, postpartum depression is not 
regularly screened for in Romania. The study identifies 
the possible need for appropriate and constant assessment 
of postpartum depression and the establishment of an 
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appropriate medical structure to identify and mitigate the 
risks of postpartum depression. 
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